Xia, Tian
Tian, Hui
Zhang, Kaiwen
Zhang, Siyu
Chen, Wenhui
Shi, Si
You, Yiwen
Funding for this research was provided by:
National Natural Science Foundation of China (No. 81972554, No. 81672682, No. 81702707)
Clinical Frontier Technology of Jiangsu (No. BE2017680)
Natural Science Foundation of Jiangsu (No. BK20201208)
CSCO Clinical Oncology Research Foundation of Beijing (No. Y-HS2017-074)
Article History
Received: 15 June 2021
Accepted: 20 August 2021
First Online: 8 September 2021
Declarations
:
: The research was approved by the Ethics Committee of Affiliated Hospital of Nantong University (No.2018-L049) and in accordance with the 1964 Declaration of Helsinki. Written informed consent was obtained from all the participants. Studies in animals were approved by the committee on the Ethics of Animal Experiments of Nantong University (RDD number:20180227–008). The experiments were followed NIH Guidelines and were approved by the Administration Committee of Experimental Animals, Jiangsu Province, China (Approval ID:SYXK(SU)2007–0021).
: Not applicable.
: The authors declare that they have no competing interests.